1Ishii K, Takamura N, Shinohara E, et al. Intracellular cytokine analysis of CD4 - positive T cells predictive of sustained response to interferon therapy for patients with chronic hepatitis C[J] .Dig Dis Sci, 2002, 47:778 - 783.
2Cramp ME, Rossol S, Chokshi S, et al. Hepatitis C virus- specific Tcell reactivity during interferon and ribavirin treatment in chronic hepatitis C[J]. Gastroenterology, 2000,118:346-355.
3Alvarado Esquivel C, Elewaut A, Philippe J, et al. Evolution of hepatitis C virus - specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon- α[J].Rev Invest Clin, 2002,54:41-50.
4Hempel G, Galle PR, Lohr HF. Quantitative analysis of specific Thl/ Th2 helper cell responses and IgG subtype antibodies in interferon - α treated patients with chronic hepatitis C[J] .J Med Virol, 2001,125:356-377.
5Eckels DD, Tabatabail N, Bian TH, et al. In vitro human Th - cell responses to a recombinant hepatitis C virus antigen: failure in IL- 2 production despite proliferation[J] .J Hum Immunol, 1999, 60:187-199.
6Diepolder HM, Gruener NH, Gerlach JT, et al. Different levels of Tcell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4+T-cell clones[J] .J Virol, 2001, 75:7803 - 7810.
7Lancaster T, Sanders E, Christie Jm, et al. Quantitative and functional differences in CDs+ lymphocyte rsponses in resolved acute and chronic hepatitis C virus[J].J Viral Hepat, 2002, 9:18-28.
8Vertuani S, Bazzaro M, Gualandi G, et al. Effect of interferon - alpha therapy on epitope- specific cytotoxic T lymphocyte responses in hepatitis C virus individuals[J] .Eur J Immunol, 2002, 32:144 - 54.
9Gruener NH, Lechner F, Jung MC, et al. Sustained dysfunction of aniviral CD8^+ T lymphocytes after infection with hepatitis C virus[J]. J Virol, 2001,75: 5550 - 5558.
10Luft T, Pang KC, Thomas E, et al. Type I IFNs enhance the terminal differentiation of dendritic cells[J]. J Immunol, 1998, 161:1947 - 1953.
